Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Recruiting

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns

NCT06551220

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Dana-Farber Cancer Institute, Harvard Medical School Boston, Massachusetts, United States
  • Fujian Cancer Hospital, Fujian Medical University Fuzhou, Fujian, China
  • The 10th Affiliated Hospital of Southern Medical University Dongguan, Guangdong, China
View all 26 locations
View Trial Details
Recruiting

A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.

NCT07593820

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +12 more
Locations
  • Hospital Del Mar Barcelona, Catalonia, Spain
  • Hospital Universitari Vall D Hebron Barcelona, Catalonia, Spain
View Trial Details
Recruiting

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

NCT06246968

Conditions
Breast Cancer, Breast Cancer Stage IV, Breast Diseases, +11 more
Locations
  • Memorial Sloan Kettering Cancer Center at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

A Study of Surgery and Radiotherapy in People With Breast Cancer

NCT07053085

Conditions
Breast Diseases, Breast Neoplasms, HER2-positive Breast Cancer, +5 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
View Trial Details
Recruiting

A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy

NCT07071337

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • The Fifth Medical Center of the Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

NCT05846789

Conditions
Breast Diseases, Breast Neoplasms, Estrogen-receptor-low Breast Cancer, +7 more
Locations
  • Emory University Atlanta, Georgia, United States
  • IU Health Joe and Shelly Schwarz Cancer Center Carmel, Indiana, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
View Trial Details

Related conditions